Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context

Journal of Neuroendocrinology

Volumn 12, Issue 3, 2000, Pages 245-254

  Meijer, O C ^a,b,c   Williamson, A ^b   Dallman, M F ^a   Pearce, D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Glucocorticoid; Hippocampus; Mineralocorticoid; NF kB p65 RelA; Sp1; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINERALOCORTICOID RECEPTOR; NEUROTRANSMITTER; PROTEIN SUBUNIT; SEROTONIN 1A RECEPTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HIPPOCAMPUS; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAPHE NUCLEUS; RAT; RECEPTOR GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; CORTICOSTERONE; GENE DELETION; HIPPOCAMPUS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEQUENCE ANALYSIS, DNA; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0034021821     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00445.x     Document Type: Article

References (51)

1. De Kloet ER. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991; 12: 95-164.
2. Herman JP. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell Mol Neurobiol 1993; 13: 349-372.
3. Chalmers DT, Kwak SP, Mansour A, Akil H, Watson SJ. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci 1993; 13: 914-923.
4. Zhong P, Ciaranello RD. Transcriptional regulation of hippocampal 5-HT1A receptors by corticosteroid hormones. Mol Brain Res 1995; 29: 23-34.
5. Chalmers DT, Watson SJ. Comparative anatomical distribution of 5-HT1a receptor mRNA and 5-HT1a binding in the rat brain: a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res 1991; 561: 51-60.
6. Pompeiano M, Palacios JM, Mengod G. Distribution and cellular localization of mRNA coding for the 5-HT1a receptor in the rat brain: correlation with receptor binding. J Neurosci 1992; 12: 440-453.
7. Miquel MC, Doucet E, Boni C, El Mestikawy S, Matthiesen L, Daval G, Vergé Hamon M. Central serotoninla receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem Int 1991; 19: 453-465.
8. Tejani-Butt SM, Labow D. Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: an autoradiographic analysis. Psychopharmacology 1994; 113: 481-486.
9. Meijer OC, De Kloet ER. Corticosterone suppresses the expression of 5-HT1a receptor mRNA in rat dentate gyrus. Eur J Pharmacol Mol Pharm Section 1994; 266: 255-261.
10. Meijer OC, De Kloet ER. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 1998; 12: 1-20.
11. Holmes MC, Yau JLW, French KL, Seckl JR. The effect of adrenalectomy on 5-hydroxytryptamine and corticosteroid receptor subtype messenger RNA expression in the rat. Neuroscience 1995; 64: 327-337.
12. Drouin Sun YL, Chamberland M, De Gauthier Y, Lean A, Schmidt TJ. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 1993; 12: 145-156.
13. Malkoski SP, Handanos CM, Dorin RI. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol Cell Endocrinol 1997; 127: 189-199.
14. Jonat C, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H, Herrlich P. Antitumor promotion and antiinflammation: downmodulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189-1204.
15. Yang-Yeng HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin Karin M. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein protein interaction. Cell 1990; 62: 1205-1215.
16. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 1990; 62: 1217-1226.
17. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kB and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752-756.
18. Diamond MI, Miner JN, Yoshinga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990: 249: 1266-1272.
19. Zhang XK, Dong JM, Chiu JF. Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. J Biol Chem 1991; 266: 8248-8254.
20. Mittal R, Kumar KU, Pater A, Pater MM. Differential regulation by c-jun and c-fos protooncogenes of hormone response from composite glucocorticoid response element in human papilloma virus type 16 regulatory region. Mol Endocrinol 1994; 8: 1701-1708.
21. Miner JN, Yamamoto KR. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev 1992; 6: 2491-2501.
22. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by non-receptor factors at a composite response element. Science 1993; 259: 1161-1165.
23. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato ACB. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 1994; 13: 4087-4095.
24. Trapp T, Rupprecht R, Castren M, Reul JMHM, Holsboer F. Heterodimerization between mineralocorticoid receptor and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 1994; 13: 1457-1462.
25. Liu W, Wang J, Sauter NK, Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 1995; 92: 12480-12484.
26. Kuroda Y, Watanabe Y, Albeck DS, Hastings NB, McEwen BS. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5 HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res 1994; 648: 157-161.
27. Meijer OC, De Kloet ER. A role for the mineralocorticoid receptor in a rapid and transient suppression of 5-HT1A receptor mRNA by corticosterone J Neuroendocrinol 1995; 7: 653-657.
28. Albert PR, Zhou QY, van Tol HHM, Bunzow JR, Civelli O. Cloning, functional expression and mRNA tissue distribution of the rat 5-Hydroxytryptaminel a receptor gene. J Biol Chem 1990; 10: 5825-5832.
29. Heinemeyer T, Wingender E, Reuter I, Hermjakob H. Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA. Kolpakov FA, Podkolodny NL, Kolchanov NA. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl Acids Res 1998; 26: 362-367.
30. Eves EM, Tucker MS, Roback JD, Downen M, Rich Rosner M, Wainer BH. Immortal rat hippocampal cell lines ehxibit neuronal and glial lineages and neurotrophin gene expression. Proc Natl Acad Sci USA 1992; 89: 4373-4377.
31. Meijer OC, Dallman MF, Pearce D. 5-HT1A receptor expression in immortalized hippocampal neuronal cells: a model for the regulatory effects of corticosteroids. Soc Neurocsi 1997; 818: 13 (abstract).
32. Parks CL, Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 1996; 271: 4417-4430.
33. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of 1 kappa B. Science 1995; 270: 286-290.
34. Schoenherr CJ, Anderson DJ. The neuron-restrictive silencing factor: a coordinate repressor of multiple neuron-specific genes. Science 1995; 267: 1360-1363.
35. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC, Altshuller YM, Frohman MA, Kraner SD, Mandel GREST. a mammalian silencing protein that restricts sodium channel expression to neurons. Cell 1995; 80: 949-957.
36. Weber JRM, Skene JHP. Identification of a novel repressive element that contributes to neuron-specific gene expression. J Neurosci 1997; 17: 7583-7593.
37. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998; 76: 480-489.
38. Ausubel FM, Brent R, Kingston RE, Mooore DD, Seidman JG, Struhl K, Chanda VB, eds. Current Protocols in Molecular Biology. New York: J. Wiley & Sons, 1997.
39. Saffer JD, Jackson SP, Annarcla MB. Developmental expression of sp1 in the mouse. Mol Cell Biol 1991; 11: 2189-2199.
40. Ammendola R, Mesuraca M, Russo T, Cimino F. Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues. J Biol Chem 1992; 267: 17944-17948.
41. Meberg PJ, Kinney WR, Valcourt EG, Routtenberg A. Gene expression of the transcription factor NF-kB in hippocampus: regulation by synaptic activity. Mol Brain Res 1996; 38: 179-190.
42. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Bauerle PA. Constitutive NF-kB activity in neurons. Mol Cell Biol 1994; 14: 3981-3992.
43. Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H. Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet 1998; 81: 434-439.
44. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ. A cooperative interaction between NF-kB and sp1 is required for HIV-1 enhancer activation. EMBO J 1993; 12: 3551-3558.
45. Caldenhoven E, Liden J, Wissink S, van de Stolpe A, Raaymakers J, Koenderman L, Okret Gustafsson J, van der Saag PT. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 1995; 9: 401-412.
46. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. Characterization of mechanisms involved in transrepression of NF-kB by activated glucocorticoid receptors. Mol Cell Biol 1995; 15: 943-953.
47. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 1998; 12: 45-56.
48. Reul JMHM, De Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985; 117: 2505-2511.
49. Linthorst ACE, Flachskamm C, Müller-Preuss P, Holsboer F, Reul JMHM, Effect of bacterial endotoxin and interleukin-1ß on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J Neurosci 1995; 15: 2920-2934.
50. Flugge G, Pfender D, Rudolph S, Jarry H, Fuchs E. 5HT1A-receptor binding in the brain of cyclic and ovariectomized female rats. J Neuroendocrinol 1999; 11: 243-249.
51. Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC. RAP46 is a negative regulator of glucocorticoid receptor action and hormone-inducedapoptosis. J Biol Chem 1998; 273: 14620-14625.